UNITY Biotechnology to Participate in Upcoming Investor Conferences

Rhea-AI Summary

UNITY Biotechnology, Inc. (Nasdaq: UBX) announced participation in key investor conferences this September, aimed at discussing their innovative therapeutics targeting aging diseases. The company will hold one-on-one meetings at the Citi 17th Annual BioPharma Conference from September 6-8 in Boston, and present a corporate update at the H.C. Wainwright 24th Annual Global Investment Conference on September 12 at 4 PM ET, available via webcast. UNITY focuses on treatments that eliminate senescent cells to benefit age-related ophthalmologic and neurologic conditions.

SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will participate in the following investor conferences in September.

Citi 17th Annual BioPharma Conference
Format: One-on-one investor meetings
Date: September 6 – 8, 2022
Location: Four Seasons Hotel Boston, Massachusetts

H.C. Wainwright 24th Annual Global Investment Conference
Format: Corporate update presentation and one-on-one investor meetings
Date and Time: Monday, September 12, 2022 at 4 PM ET
Location: Virtual

A live webcast of the H.C. Wainwright presentation is available by clicking here and will also be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITY
UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.

Media Contact:
Evoke Canale
Jason Spark
Jason.spark@evokegroup.com

Investor Contact:
Joyce Allaire
LifeSci Advisors
212-915-2569
jallaire@lifesciadvisors.com

Source: Unity Biotechnology, Inc

FAQ

What conferences will UNITY Biotechnology (UBX) participate in September 2022?

UNITY Biotechnology will participate in the Citi 17th Annual BioPharma Conference from September 6-8 and the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022.

Where is the Citi BioPharma Conference located?

The Citi 17th Annual BioPharma Conference will take place at the Four Seasons Hotel in Boston, Massachusetts.

How can I access the live webcast of UNITY's presentation at the H.C. Wainwright conference?

You can access the live webcast of UNITY's presentation at the H.C. Wainwright conference on their official website or by following the provided link in their press release.

What is the focus of UNITY Biotechnology's current research?

UNITY Biotechnology is focused on developing therapeutics to slow, halt, or reverse diseases of aging, specifically targeting the elimination of senescent cells.

What date and time is UNITY's presentation at the H.C. Wainwright conference?

UNITY's presentation at the H.C. Wainwright 24th Annual Global Investment Conference is scheduled for September 12, 2022, at 4 PM ET.